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New advances in MR-compatible bioartificial
liver
Rex E. Jeffriesa and Jeffrey M. Macdonalda*
MR-compatible bioartificial liver (BAL) studies have been performed for 30 years and are reviewed. There are two
types of study: (i) metabolism and drug studies using multinuclear MRS; primarily short-term (< 8h) studies; (ii) the
use of multinuclear MRS andMRI to noninvasively define the features and functions of BAL systems for long-term liver
tissue engineering. In the latter, these systems often undergo not only modification of the perfusion system, but also
the construction of MR radiofrequency probes around the bioreactor. We present novel MR-compatible BALs and the
use of multinuclear MRS (13C, 19F, 31P) for the noninvasive monitoring of their growth, metabolism and viability, as
well as 1H MRI methods for the determination of flow profiles, diffusion, cell distribution, quality assurance and
bioreactor integrity. Finally, a simple flexible coil design and circuit, and life support system, are described that can
make almost any BAL MR-compatible. Copyright  2011 John Wiley & Sons, Ltd.
Keywords: MR-compatible bioreactor; radiofrequency probe construction; bioartificial liver; 31P MRS; 13C MRS; 19F MRS;
1H MRI
INTRODUCTION
MRS studies of cell preparations permit the control of cell
composition and the evaluation of contributions from immune,
endocrine, paracrine and physicochemical parameters not
afforded in intact or perfused organ systems [for reviews, see
refs. (1–6)]. Since 1973, four categories of MR-compatible
mammalian cell perfusion systems have evolved (7):
(i) suspension (8); (ii) entrapment (9–12); (iii) microcarrier
(4,13); and (iv) membrane (14). Table 1 contains some MR and
physiological metrics for comparison of these various bioreactor
categories.
Although MR-compatible bioartificial livers (BALs) have been
used for three decades (15), the lack of long-term cell viability and
the complexity of bioreactor operation have hindered their
widespread application in the pharmaceutical industry. Initially,
MR-compatible bioreactors for hepatocytes, or BALs, used
hepatocyte suspensions, but function and viability only persisted
for several hours before hypoxia caused cell death (8,16–18). This
is because suspension bioreactors are the only category in Table 1
without perfusion, and thereforemass transfer is themost limited
of all categories. However, from an MRS standpoint, they are easy
to operate, have excellent global density (i.e. the percentage of
sensitive volume in the coil filled by cells) leading to a superior
signal-to-noise ratio (SNR), and can be packed in a 5-mm
NMR tube, so that standard high-resolution NMR spectrometers
can be used.
The goal of these early studies was not to maintain long-term
viability, but to obtain short-term metabolic information, and
a few hours were all that was required for this goal. This
simple suspension BAL evolved to perfusion systems in which
hepatocytes were entrapped in collagen threads (19–25) or
alginate spherical encapsulates (26–28), or inoculated into
membrane bioreactors (29). The most widely applied method
for metabolism studies is the entrapment technique, whereby
cells are immobilized in threads of agarose (30) or alginate (9,11).
All early BAL studies used nonphysiological concentrations of
oxygen, typically 95 : 5 oxygen : carbon dioxide (carbogen) (15), in
order to overcome hypoxia, whereby, in vivo, the blood contains
hemoglobin to reduce the oxygen gradient across the liver
(Table 1). In addition, simple salt solutions or nonbasal medium
solutions were used (Table 1), which is not permissive for
long-term cultures, and more typical of toxicology studies (31).
More recently, with the advent of tissue engineering, MRS and,
especially, MRI have been used as tools to characterize the
bioreactor, with MRS focusing on 31P and viability (16–26,29),
and no reported studies of 13C, 15N, 1H or 19F to characterize
tissue-engineered BAL function. Recently, dynamic nuclear
polarization 13C MRS has been used to determine flux rates
in alginate-entrapped rat hepatoma cells perfused in a fluidized-
bed BAL (32); however, this review focuses on in vivo MR studies
of primary hepatocytes. 1H MRI has been used to investigate
inoculation efficiency and distribution, as well as to obtain quality
assurance data (29), and velocity-encoded MRI has been used to
define the flow characteristics (33); diffusion-weighted MRI and
other forms have not yet been applied to BAL. One reason for this
lack of MR research is that conventional BAL systems do not fit in
vertical bore magnets and require horizontal bore magnets,
which typically do not possess a second broad-band channel for
multinuclear MRS analysis, and/or there are no easy instructions
to make BALs MRS- and MRI-compatible. This review provides an
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easy step-by-step approach to make any BAL MR-compatible,
and presents examples of the application of multinuclear MRS
protocols to monitor the viability and function of several BAL
designs, as well as MRI applications to characterize inoculation
efficiency and distribution in opaque materials, quality assurance,
flow dynamics and oxygen distribution.
As suspension BALs were the first design attempted, and
are not feasible for long-term maintenance of liver cells in
tissue engineering (Table 1), they are not used for the
demonstration of MRS and MRI applications in this review.
Rather, three bioreactors corresponding to membrane, micro-
carrier and entrapment, which have been tested by MRS
and MRI in the author’s laboratory, are used to demonstrate
the applications of MRS and MRI, whilst demonstrating the
effects of various bioreactor parameters on hepatocyte viability,
such as the diffusion distance, shear forces, channeling and
the gelling or aggregation of hepatocytes. Figure 1 includes
diagrams and photographs of the three bioreactors that
are presented: (i) hollow fiber membrane bioreactor inoculated
with microcarriers; (ii) membrane multicoaxial hollow fiber
bioreactor; and (iii) fluidized bioreactor consisting of alginate-
entrapped hepatocytes.
Figure 1. The three bioartificial liver (BAL) designs described: hybrid hollow fiber–microcarrier bioreactor; multicoaxial hollow fiber membrane
bioreactor; and fluidized-bed encapsulation bioreactor. Three photographs of the bioreactors (A) with details of their design (B) and flow patterns (C). ECC,
extracapillary compartment; ICC, intracapillary compartment.





MRS AND MRI COMPATIBILITY – BUILDING
COMPACT RADIOFREQUENCY (RF) MR
PROBES FOR BALS
MR probes cost tens of thousands of dollars if purchased from a
commercial vendor, but can be easily constructed with minimal
experience beyond a novice education in RF engineering (34). For
animal studies, a knowledge of building one’s own MR probe is
essential as one may need to change the coil geometries based
on the region of interest and, for some BAL designs, this may also
be the case. The majority of available NMR spectrometers are
vertical bore instruments, and a volume coil is used, wherein the
entire central portion of the BAL is contained within the MR coil.
For animals, typically surface coils are used to localize to the
tissue of interest, and typically the MR probe is designed for a
horizontal bore magnet for rats or larger animals. MR probe
designs for horizontal and vertical bore magnets are similar, but
MR probes for horizontal-bore magnets have larger cradles and
typically do not need the RF aluminum casing to shield the
electronics from the room temperature shims because of the
increased distance between the MR probe circuitry and shim or
gradient coils. Several MR probe designs for the larger horizontal
bore magnets can be found in the literature (29,35).
A drawing of a generalized perfusion loop for a BAL is shown in
Fig. 2 with the various components. Everything present in a
standard life-support unit of a BAL system is present in the
MR-compatible system, except that the perfusion lines are
lengthened and the recommended heating and oxygenation are
in parallel and near the magnet. There are two benefits to this: (i)
the perfusion medium can be maintained at room temperature,
inhibiting bacterial growth and the degradation of medium
components, such as glutamine; and (ii) there is no outgassing in
the bioreactor as a result of a decrease in solubility of oxygen
caused by an increase in temperature in the magnet. An
MR-compatible, autoclaveable gas exchange/heater module has
been described that solves these issues (36). It is very important
to place a bubble trap just before the medium line enters the
bore at the top of the vertical bore magnet. Bubbles can become
trapped inside the BAL and destroy spectral quality because of
the enormous magnetic susceptibility effects caused by the
air–water interface.
Figure 2 shows the in-line oxygen electrodes to monitor
oxygen consumption. This is difficult with the Clark electrode
for long-term tissue engineering studies as the membrane
may become fouled and, if one monitors medium oxygen levels
periodically via ‘T’ connections throughout the study period,
these are potential sources of contamination. If oxygen con-
sumption is desired, a noninvasive fluorescent oxygen sensor
is recommended – they do not consume oxygen during the
measurement, unlike the Clark electrode, which becomes
important for small volumes. At the very least, it is essential
to measure the drop in oxygen concentration from the gas
exchangemodule down the water-jacketed line to the bioreactor,
as polyethylene tubing is extremely permeable to oxygen and
will diffuse into the water-jacket fluid, typically decreasing the
oxygen concentration once entering the BAL. Autoclaveable
fluorinated ethylenepropylene (FEPT) tubing (0.0313-in inner
diameter) is recommended, which is less oxygen permeable than
polyethylene tubing. A 20% drop from 95% oxygen exiting the
gas exchange module and traveling down a 3-ft length of tubing
at 3mL/min and 378C to the bioreactor is not unexpected. Once
this drop in oxygen concentration is measured and the flow
rate remains constant, one can assume this value for the length of
the experiment.
The fluidized-bed BAL (Fig. 1A, C), described below in the
‘entrapment bioreactor’ category, fits inside a standard 10-mm
MR probe and is lowered from the top of the magnet, as is typical
for vertical bore magnets, and uses the spectrometer VT system
to help maintain the temperature [see ref. (32)] (Fig. 2). However,
for larger oddly shaped BALs, the MR probe can be built around
the bioreactor, and the MR probe–bioreactor assembly is inserted
into the magnet from the bottom. Figure 3A shows the assembly
being inserted into an unshielded wide-bore 400-MHz NMR
spectrometer with the life-support accessories on a cart at
a distance (Fig. 3A, foreground). With shielded magnets, the
cart can be right next to the magnet and the lines much shorter.
A simple Helmholtz coil can be constructed using flexible circuitry
described previously (29) and shown in Fig. 3B. A dual,
Figure 2. Generic bioreactor life-support loop and bioreactor. Block diagram of the bioreactor loop showing the major components and the gas
exchange module that heats and oxygenates the medium simultaneously (12), so that it can be maintained at room temperature.
wileyonlinelibrary.com/journal/nbm Copyright  2011 John Wiley & Sons, Ltd. NMR Biomed. 2012; 25: 427–442




orthogonally placed Helmholtz coil permits a broad-band MR
probe to be made around the BAL (Fig. 3C), wherein the inner
coil is attached to a circuit tuned to 13C and 31P frequencies
(Fig. 3C, foreground) and the outer coil is attached to a circuit
tuned to 1H frequency (Fig. 3C, background) for decoupling and
MRI. As a result of the proximity of the room temperature shims to
the MR coil in vertical bore magnets, the BAL–MR probe cradle
assembly is inserted into an aluminum RF shield (Fig. 3D), which
runs the length of the magnet and is grounded to the magnet
at its base. It also contains a connection, in this case Bayonet
Neill–Concelman (BNC) (Fig. 3E), for coaxial cable(s) leading to the
preamplifier. Horizontal magnets provide more space, permitting
the BAL to be inserted into a large-bore 1H MR probe (Fig. 3F).
MULTINUCLEAR MRS OF A HYBRID
HOLLOW FIBER–MICROCARRIER BAL
Ugurbil et al. (37) first introduced microcarrier beads, whereby
mouse embryo fibroblasts were grown on the surface of
polymeric beads and placed in an MR-compatible perfusion
chamber for study. With microcarriers and encapsulates, a packed
bed is perfused. In the former, the global density is hindered
because the cells only attach to the outside of the microcarrier,
with microcarrier material void of cell signal, resulting in a low
cell number per unit volume of microcarrier, and thus SNR is
adversely affected (Table 1). Membrane bioreactors typically
separate the cells from the flowing perfusion solution by
Figure 3. MR compatibilization of bioartificial livers (BALs), showing the insertion of the assembly into the bottom of a wide-bore 400-MHz NMR
spectrometer (A) and the photo-etched flexible Helmholtz copper coils (B) that are wrapped around the hybrid hollow fiber–microcarrier BAL to serve as
the low-frequency coil, increasing the filling factor; this is then inserted into the outer high band coil wrapped on two semicircular glass cylinders and
soldered to the circuit in the background (C). The BAL–loop–MR probe–cradle assembly is inserted into an aluminum radiofrequency (RF) shield (D and E),
or a larger imaging probe, either commercial or home-built, can be used to obtain images, as shown by the 1H/23Na NMR probe (F).





permeable membranes, allowing the diffusion of nutrients and
waste, but restraining the cells in the bioreactor. A hollow
fiber bioreactor is amembrane system that consists of a bundle of
permeable hollow fibers running axially (14) or radially (38)
through the housing, typically capped by epoxy or thermal
welding, with medium or gas typically traveling through the
fiber lumen (39). The hybrid hollow fiber–microcarrier bioreactor
(Genespan Inc., Bothell, WA, USA) is shown in Fig. 1A, wherein
there is an annular ring of polyethylene oxygenation hollow
fibers (300-mm outer diameter) and a central bundle of nutrient
delivery cellulose acetate hollow fibers (3-mm outer diameter)
(Fig. 1B, C), and microcarriers rest in between the two bundles
and rotate 1208 on a rocker bed. Figure 4A shows the bioreactor
being inoculated via the side port with hepatocyte-coated
dextran microcarriers and, in the three experiments presented in
Fig. 4A, a total of 500 million rat hepatocytes were inoculated in
each bioreactor.
Viability by 31P MRS
The 31P MR spectrum contains viability information by monitoring
b-nucleotide triphosphate (b-NTP) over time (29), which is
approximately 80% adenosine triphosphate (ATP) in liver (40).
The first 31P MRS cell studies of hollow fiber bioreactors were used
not only to monitor cell viability, but also cell growth within the
opaque material of these bioreactors (41,42). Dale and Gillies (1)
subsequently refined the MR-compatible design to optimize global
density (i.e. the percentage of volume within the MR probe
consisting of cell mass), and enabled cell culture formanymonths to
reach tissue densities. The first MR-compatible hollow fiber BALwas
published by Macdonald et al. (29). As an example of how 31P MRS
can be used in the development of BALs, data from experiments
with a hybrid hollow fiber–microcarrier bioreactor with various
oxygen concentrations and flow configuration are given below. In
general, oxygen is always the rate-limiting nutrient in BALs and,
Figure 4. (A) Inoculation of the hybrid hollow fiber bioreactor with hepatocytes mixed with microcarriers. (B) Graphs of the percentage change in
b-nucleotide triphosphate (b-NTP) relative to b-NTP from the first spectrum of hepatocytes perfused with medium subjected to 20% and 40% oxygen,
and 20% oxygen but directly perfused through the cell compartment. (C) Analysis of the medium components after 20% and 40% oxygen treatments
with a regular flow configuration, showing the increase in lactate dehydrogenase (LDH), validating that the decrease in b-NTP is a result of cell death
(glucose and ammonia are also quantified).
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typically, a distance beyond approximately 200mm is considered to
be hypoxic (15,29,43), while physiolgically this distance ranges from
20-60mm (15,44). In order to address this issue, the 10-cm space
between oxygen and nutrient fibers (Fig. 1B) was subjected to
30–60Hz 1208 rotation on a rocking stand, and microcarriers
containing hepatocytes were inoculated into this space (Fig. 1C).
Two oxygen concentrations were tested in the hybrid hollow
fiber–microcarrier BAL: 20% and 40% oxygen with 5% carbon
dioxide with the remainder nitrogen. The bioreactor was taken
off the rocker and placed in the MR probe (Fig. 3C), and 31P MR
spectra were obtained immediately after inoculation. Figure 4B
shows the time courses of the b-NTP peak area relative to the
b-NTP peak area obtained in the first spectrum, expressed as the
percentage change. In all cases, b-NTP decreased precipitously
with 20% and 40% oxygen. Figure 4C shows the results of the
analysis of medium components, illustrating the increase in
lactate dehydrogenase in both 20% and 40% oxygen treatments,
confirming cell death. One of the main problems with
hepatocytes is that the cell surface adhesion proteins, such as
cadherin, cause hepatocytes to aggregate and, indeed, this is the
mechanism by which liver spheroids are produced (31). As the
hepatocytes are on the surface of the collagen-coated micro-
carriers, and although the bioreactor is constantly rotated by 1208
on a rocker (Fig. 1C, bottom) at a period of 30Hz, the hepatocytes
still gel in the bioreactor. The gel was so solid that, in a third
experiment, the side port was perfused and a small portion of
hepatocytes near the perfusion channel remained viable for 3
days (Fig. 4B, bottom graph), completely eliminating the
usefulness of the hollow fiber bioreactor. In fact, this gelling
phenomenon makes it impossible to suspend hepatocyte-
covered microcarriers in a fluidized-bed bioreactor without
gelling (Table 1), and has required alginate/agarose encapsula-
tion methods to be employed to avoid aggregation phenomena
(see below)
Quantification of drug metabolic activity and oxygen
distribution by 19F MRS
A common functional assay for hepatocytes is the administration
of a metabolic probe, such as ethoxycoumarin, lidocaine or
benzodiazepine, to quantify cytochrome P450 activity (45).
19F MRS has been used to perform similar measurements in
whole animals (46,47) and in cells (48). Similar to a previous
19F MRS study of substituted fluorinated phenols (49) a
cytochrome P450 (IA1 and IIB1) substrate, 4-fluoroacetanilide,
was given to rats and the urinary metabolites were analyzed
(50). 4-Fluoroacetanilide is an ideal metabolic probe to test the
metabolic activity of MR-compatible BALs, because nearly all
major drug-metabolizing enzymes can be probed (50), including
acetylation/deacetylation, flavo-mononamine oxidase, cytochrome
P450s and all of the major phase II conjugating pathways (i.e.
glucuronidation, sulfation and gluthionylation), the latter requir-
ing the analysis of media streams. The relative distribution
of fluorinated metabolites in the MR-compatible BAL can be
compared with that in whole organisms (50). Scarfe et al. (50)
found, in rat, that 4-fluoroacetanilide was metabolized by
cytochrome P450 to 4-fluoro-2-hydroxyacetanilide (ortho-hydroxy
rather than para-hydroxy acetaminophen) and subsequently
conjugated to glucuronide, whereas two-fold more was
metabolized by deacetylation to 4-fluoroaniline, and then
ortho-hydroxylated by cytochrome P450, and conjugated
by sulfation. This metabolic probe is well resolved in the
19F MR spectrum, with the two major metabolites, P450-
oxidized glucuronide and deacetylated-sulfate conjugates,
resonating at – 4.2 ppm andþ 6.8–ppm, respectively from the
parent compound. This permits sufficient resolution to
monitor drug metabolism kinetics noninvasively, as shown in
Fig. 5, which demonstrates an increase in the peak upfield from
the parent.
Figure 5. 19F MR spectral time course of the metabolic probe, 2-fluoroacetanilide, and its metabolite, 2-fluoroaniline, with their structures andmetabolic
pathway (top). Each spectrum required 1 h to acquire. The hybrid hollow fiber was used and inoculated with microcarriers coated with rat hepatocytes
and perfused with Dulbecco’s modified Eagle’s medium oxygenated with 20% oxygen : 5% carbon dioxide : 75% nitrogen. The fluorinated metabolic
probe was added to the medium after 24 h of 31P acquisition, as shown in Fig. 4B for 20% oxygen treatment (top graph); therefore, the time course starts
at 25 h post-inoculation.





To demonstrate the in situ analysis of drug metabolism in
an MR-compatible BAL, 2-fluoroacetanilide, rather than
4-fluoroacetanilide, was used, because this compound could
be metabolized by cytochrome P450 directly to the fluorinated
acetaminophen analog, 2-fluoro-5-hydroxyacetanalide (para-
hydroxy rather than ortho-hydroxy). The metabolism of
2-fluoroacetanilide was monitored by 19F MRS in the hollow
fiber–microcarrier BAL, shown in Fig. 1A, using 20% oxygen.
Although the medium was oxygenated with 20% oxygen and the
hepatocytes were in the process of dying, as supported by the 31P
MR spectral course shown in Fig. 4B (top graph), they still
metabolized the substrate (Fig. 5). After 24 h of 31P time course
(Fig. 4B, top graph), 2-fluoroacetanilide was added to the
perfusion medium consisting of hormonally defined Kubota’s
medium (33), and 1-h 19F MR spectra were obtained using the
outer high band coil (Fig. 3C, in background), which required about
3–4h to equilibrate with the gelled tissue mass (Fig. 5 – time to
plateau of parent) in the cell compartment (Fig. 1B, left drawing).
The fluorinated metabolite initially increased over 10h and then
leveled off, and the parent did not change, indicating death of the
BAL culture. Interestingly, deacetylase activity continued for at
least 10–12h (Fig. 5 – time to plateau of metabolite) after b-NTP
was no longer detectable (Fig. 4B, top graph), as supported by the
increase in the peak upfield from the parent (Fig. 5). As expected,
the downfield peak representing direct cytochrome P450
hydroxylationwas not detected (50). The proportion or distribution
of hepatocytes within the BAL metabolizing the compound was
not determined. This is the first demonstration of the use of 19F
MRS to measure drug metabolic activity within BALs, and one
could fit the 19F MRS time course to the appropriate function in
order to derive the kinetic rate constants for the respective
metabolic pathways, with periodic testing over weeks and months
of culture to determine long-term function.
19F MRI has been demonstrated to image oxygen concen-
trations within a coaxial hollow fiber bioreactor (51), but has not
yet been performed with BALs. This method perfuses a
perfluorinated hydrocarbon into the bioreactor, and T1 maps
are obtained across the bioreactor in order to obtain the
oxygen concentration. One problem with this method is that
perfluorinated hydrocarbons are highly lipophilic (52,53) and
thus are retained in the bioreactor, and they are peroxisome
proliferators (54).
1H MRI OF A HOLLOW FIBER
MULTICOAXIAL BAL
MRS and MRI in the field of tissue engineering have primarily
studied membrane BALs, in the form of a hollow fiber bioreactor.
Hollow fiber bioreactors typically possess sufficient mass transfer,
but relatively poor global densities, and thus poor SNR for MRS
(Table 1), because much of the sensitive volume within the MR
probe is filled with bioreactor material. A coaxial hollow fiber
bioreactor is composed of a fiber within a fiber (Fig. 1B, middle
drawing) and can replicate the dimensions of the liver lobule (15).
The first published MRI studies of a hollow fiber bioreactor were
of a coaxial design to investigate fiber concentricity and cell
distribution (55). They found that, although central fibers were
constructed asymmetrically, the cell culture of a mouse
hybridoma cell line apparently centered the fiber. As the
bioreactor was opaque and composed of polypropylene, MRI
was the only method to observe the soft tissue cultured cells in
the annular space between fibers (Fig. 1B, middle drawing).
BAL integrity and quality assurance
Simple T1-weighted or T2-weighted
1H MRI can be extremely
useful in determining BAL integrity, with several specific examples
of the use of 1H MRI with hollow fiber bioreactors. For example,
polypropylene hollow fibers require wetting by ethanol in order
to become permeable to water. This is called the ‘wetting’ process
and, if not performed correctly, there will be no flow across these
fibers and the cells required to be perfused by these dry fibers
will die as a result of a lack of diffusion of medium and oxygen.
T2-weighted images reveal hypointense regions, which identify
the dry fibers. The reader is referred to Macdonald et al. (29) to
show how T2-weighted MRI was used to monitor BAL wetted
fibers, and how the wetting process was modified to ensure that
all fibers were thoroughly wetted. In a similar study with cell lines,
diffusion-weighted MRI was employed to monitor fiber breach in
extremely fragile hollow fibers made of cellulose acetate (56)
using an MR-compatible bioreactor by Gillies et al. (14). In this
case, there was a dramatic change in diffusion-weightedMRI after
the cells had reached confluency, and the pressure from the
growing cell mass on the fiber walls caused them to break (56).
Quality assurance of the bioreactor is also an important
application of simple T1-weighted or T2-weighted
1H MRI.
Figure 6A shows transaxial T2-weighted
1H MRI of two prototypes
containing 18 (left) and 40 (right) fiber pairs (29). The images
define the three compartments of the coaxial bioreactor: (i) the
intracapillary compartment (ICC); (ii) the annular space; and
(iii) ECC. MRI was not only used to determine the global densities
of the two prototypes, employingMRI area analysis of the annular
compartment divided by the total cross-sectional area of the
Figure 6. (A) Transaxial T2-weighted MRI of two coaxial hollow fiber
prototypes, with 18 (left) and 40 (right) fiber pairs with diffusion distances
of 500 and 200mm, respectively. (B) The enlargement of a partially (left)
and completely (right) filled fiber pair from the 18- and 40-fiber pair
prototypes. The effect of flow results in hypointensity in the intracapillary
compartment (ICC) (B, right image). Modifications of images from
Macdonald et al. (29).
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bioreactor (diameterp), but also for quality assurance. Both
prototypes are made of polypropylene and are reused after
extensive acid/base washing of the cell compartments. There is
residual cellular material filling the annular space, represented by
hypointense regions in MRI (Fig. 6A) within the cell compartment
(see Fig. 1B, middle drawing). Both images were obtained at the
end of an experiment after cells were forced out of the annular
space by pressure, via syringe, showing that the 18- and 40-fiber
pair prototypes had 7 and 12 fiber pairs containing hepatocyte
debris respectively, and required more stringent cleaning with
2 M NaOH (29). In addition, there is a bubble detected on the top
of the image of the 40-fiber pair prototype. This occurred as a
result of incomplete filling of the ECC (see Fig. 1B, middle
drawing); cellular material or air lodges in this location because
the bioreactor is set on its side, and this would be the top of
the bioreactor if it were on its side in a horizontal magnet (29).
Inoculation efficiency
One of the most difficult and important aspects of BAL operation
is the inoculation efficiency and distribution. Opaque bioreactors
do not permit one to observe the distribution of inoculated cells.
Macdonald et al. (29) were the first to use 1H MRI to determine
BAL inoculation efficiency (i.e. percentage of bioreactor cell
compartment filled with cell inoculate) using the coaxial
hollow fiber bioreactor. Figure 6A shows two coaxial bioreactor
prototypes with different diffusion distances, which were com-
pared to determine the effect of diffusion distance on hepatocyte
viability. As expected, when the 18-fiber pair prototype was 100%
inoculated (i.e. the entire cell space was filled), the diffusion
distance was too large and the hepatocytes died, as monitored by
31P (29). However, when the 18-fiber pair prototype was partially
filled with hepatocytes, as shown in Fig. 6B (left image), they
survived (29). Indeed, the diffusion distance was calculated for
the two prototypes from similar images shown in Fig. 6B.
In short, if not for MRI, the evaluation of the inoculation
efficiency would be extremely time consuming, and any invasive
methodmay void the cell compartment making it very difficult to
retain confidence in the results. Given that the bioreactor is
made of nonmagnetic materials, MRI is the best method for the
evaluation of bioreactor inoculation efficiency and, as demon-
strated in the example in Fig. 6, resulted in design modifications.
Flow dynamics
Hammer et al. (57) published the first use of 1H MRI to measure
flow in bioreactors, which was performed on a hollow fiber
bioreactor containing no cells. Donoghue et al. (58) followed, in
1992, using velocity-encoded MRI to determine media velocity
profiles in hollow fiber bioreactors without cells. Simple T2- and
T1-weighted MRI (29) and tailored pulse sequences (59) were first
used in BALs to observe media flow. Flendrig et al. (59) modified
the RF coil to tag the water prior to entering the sensitive volume
of the coil, wherein the flow was hyperintense, whereas
Macdonald et al. (29) simply used a standard Helmholtz coil
and T2-weighted pulse sequences. The effect of flow on
T2-weighted MRI is hypointensity, as demonstrated by comparing
the MR images in Fig. 6B. A hydrodynamic study similar to that
performed by Hammer et al. (57) was carried out with the
multicoaxial hollow fiber design, whereby velocity-encoded 1H
MRI (33) was applied to determine the velocity of flow in the inner
and outer media compartments (ICC and ECC, Fig. 1B, middle
drawing), which surround the annular cell compartment, using
the flow configuration shown in Fig. 1C. Figure 7A displays two
velocity-encoded MR images with different radial flow rates.
Specifically, radial flow was diverted from the outer fiber inward,
initially with no radial flow (0mL/min) (Fig. 7A, left) and then at
0.33mL/min (Fig. 7A, right). The flow in the ICC is so fast that it is
folded and outside the calibration curve of velocities for the MRI
experiment, and does not fit the velocity scale in Fig. 7A. However,
flow in the ECC is laminar. The difference in velocity profiles of the
two MR images resulted in a radial flow rate that was the same as
the measured difference between the ICC and ECC flow rates, as
determined using a graduated cylinder to quantify the volumes
exiting ECC and ICC (33). The velocity-encoded MRI confirmed
benchtop studies showing that the outer polysulfone hollow fiber
had a permeability that was two orders of magnitude higher than
that of the inner fiber, and thus radial flow at physiological
pressures was not possible (33). Indeed, this single finding led to
the development of a second-generation bioreactor, whereby the
outer, relatively impermeable polysulfone fiber was replaced with
a woven vasculature that was 3mm in diameter, wherein
permeability could be easily modified by the weave tightness and
curing process (60,61).
One interesting discovery was that, with no radial flow from
ECC to ICC, there was axial flow in the annular cell compartment
(Fig. 1B, middle drawing) using a configuration with the ECC and
ICC flows in the same direction (Fig. 1C, see flow arrows).
Figure 7A (left) shows axial velocity-encoded MRI, indicating no
Figure 7. (A) Transaxial velocity-encoded MRI of the multicoaxial hollow
fiber bioreactor (inset) at two inward radial flow rates. Note the difference
in flow of the extracapillary compartment (ECC) between the two flow
rates, and that the intracapillary compartment (ICC) flow is out of the
range of velocities calibrated for the MRI experiment and is thus folded.
The FIDAP (Fluid Dynamics Analysis Package) theoretical analysis of flow
in the three compartments is given in (B). Note that the laminar nature
matches the ECC and cell compartments, and predicts a higher velocity
profile in the ECC. Qrad, radial flow. Reproduced by permission from
Wolfe et al. (33).





radial flow, yet there is axial flow in the cell compartment. Using
the hydraulic permeability of the two hollow fibers determined
from benchtop studies (33), FIDAP (Fluid Dynamics Analysis
Package, Fluid Dynamics International, Ltd., Taplow, UK)
simulations of flow (Fig. 6B) predicted that there is axial Starling
flow in the cell compartment when there is flow in the ICC,
because of the two order of magnitude higher permeability of
this inner hollow fiber (33). This flow diminishes axially as a result
of the Starling flow effect, whereby the radial flow reverses
direction and goes back into the ICC because of the drop in
pressure across the ICC from inlet to outlet. This is because the
pressure is higher in the ICC at the inlet than in the cell
compartment, but reverses at the outlet. Of course, when the cell
compartment is filled with cells, unless there are axial conduits for
the flow, this axial flow will not occur in the cell compartment
because of the resistance caused by the cell mass. Another
observation confirmed by MRI is that the flow is laminar in the
ECC and cell compartment (Fig. 6A), as predicted by the FIDAP
model (Fig. 6B), but is off scale in MRI for the ICC. However, the
MRI pulse sequence could be re-calibrated to include the high
flow rate of the ICC on the velocity scale, but resolution for the
lower flow rates will decrease, and perhaps become undetect-
able, given the same acquisition time. This demonstrates the type
of empirical data generated by velocity-encoded 1H MRI for the
characterization of transport phenomena in BALs, and how they
can be compared with models of flow to corroborate the results.
MRI compares with other modalities, such as acoustic and laser
Doppler velocimetry, because it is noninvasive with little need for
BAL modification for the flow measurement. That is, BAL can be
made MR-compatible (Fig. 2) and placed directly in the MRI for
observation.
Diffusion-weighted and fast gradient echo sequence (FAST)
dynamic contrast MRI
The first demonstration of diffusion dampening 1H MR pulse
sequences to monitor the cell region rather than the medium
region was performed in a packed-bed bioreactor of encapsu-
lated breast cancer cells (MCF-7) in agarose threads (62), and later
in a hollow fiber bioreactor (58). As mentioned above,
diffusion-weighted 1H MRI was first used by Callies et al. (56)
to evaluate cell growth. The theoretical limit of MRI is about 5mm
(63) and, therefore, with hepatocytes ranging from 7 to 25mm
(15,31), it is unlikely that they will be resolved without the
addition of a ferromagnetic nanoparticle contrast agent (64),
which could affect the biology. An ideal application, however, is
the formation of organoids (65) after isolated liver cells have been
cultured for several days. Hepatocytes move with philopodia and
can aggregate in extracellular matrices (66). Capuani et al. (67)
used diffusion-weighted 1H MRI to determine the cellular volume
of hepatocytes encapsulated in alginate beads, and this would be
ideal for the noninvasive monitoring of the movement and
aggregation of hepatocytes into organoids within BALs; however,
it has not been demonstrated. For example, Fig. 8 shows a
multicoaxial BAL inoculated with a 1 : 1 ratio of MatrigelTM :
collagen type 1 with 4 million hepatocytes; another BAL was
inoculated with alginate-encapsulated hepatocytes, as described
by Seagle et al. (68). The BALs were maintained for 30 days, and
then the coaxial fiber was extricated and 6-mm-thick slices were
cut with a microtome and stained with live–dead dye to visualize
the hepatocytes. With the MatrigelTM: collagen type 1 mixture,
the hepatocytes aggregated, forming an annulus over the full
length of the bioreactor (Fig. 8A1-3), whereas the alginate beads
did not aggregate as strongly (Fig. 8C1-4). Diffusion-weighted
1H MRI would have been an ideal modality to noninvasively
monitor this aggregation process and to determine the point at
which aggregation was complete.
Planchamp et al. (35,69) used a hollow fiber BAL inoculated
with rat hepatocytes as a model to investigate the pharmaco-
kinetics of contrast agents employing dynamic T1-weighted FAST.
The goal was not to use MRI to determine the distribution or
function of the tissue-engineered system, but rather to use BAL
as a liver model to investigate the disposition and biotransport
of the imaging contrast agent, gadolinium benzyl-oxypro-
pionictetraacetate. Lanthanide metals are phagocytosed by the
liver’s resident macrophages, Kupffer cells, and cesium is used to
eliminate or kill these cells (70). Therefore, depending on the
goals and composition of the cell cultures, especially if one
employs a co-culture of parenchymal and nonparenchymal cells,
one should consider the potential toxic effects of gadolinium
contrast agents on BAL biology prior to using dynamic contrast
MRI.
31P AND 13C MRS OF A FLUIDIZED-BED BAL
CONTAINING ENCAPSULATED
HEPATOCYTES
As mentioned above, the first 31P and 13C MRS of an
MR-compatible BAL was published over three decades ago (8).
The biolimiting nutrient has always been oxygen and, in order to
overcome the large diffusion distances, higher concentrations of
oxygen have been used for long-term viability, as demonstrated
in Fig. 4 and Table 1. Although some attempts have beenmade to
use oxygen carriers in the encapsulation matrix to increase
oxygen content (52), the incorporation of perfluorinated
hydrocarbons to increase oxygen delivery to hepatocytes has
been inconclusive. Perfluorinated hydrocarbons do not exhibit
the Bohr effect associated with hemoglobin and, at lower oxygen
tension, do not release oxygen, thereby leading to higher levels
of hypoxia at low oxygen tensions than found in their absence
(53). Nevertheless, their use in media is advantageous; however,
nearly 60% is required in perfused organs (71), and perfluorinated
hydrocarbons have toxic side effects (54). Therefore, BAL
studies have focused on modulating the oxygen tension
(15,31). Although membrane bioreactors typically have the best
mass transfer, because homogeneous diffusion distances can be
maintained, they suffer from poor SNR because of insufficient
global density, and often have significant bulk magnetic
susceptibility that diminishes the resolution (Table 1).
One advantage of a fluidized-bed bioreactor is that the SNR is
good, as the diffusion distance of a membrane bioreactor is
maintained by simply keeping a homogeneous diameter, whilst
thoroughly percolating the beads in the fluidized bed. Indeed, if
the diameter is 0.5mm, this is the distance across the liver acinus,
and the diffusion gradients associated with the three zones of the
liver acinus can be re-created with a sphere (Fig. 1B, right
drawing). For example, Fig. 9A shows a comparison of the in vivo
31P MR spectra obtained from a fluidized-bed bioreactor at 9.4 T
and a coaxial bioreactor at 4.7 T; the times to acquire the 31P MR
spectra were 30 and 60min, respectively. Although the field
strength was halved with the hollow fiber bioreactor (4.7 vs 9.4 T),
the inherent T2
 values in the hollow fiber bioreactor are
significantly less, as a result, especially, of the magnetic
wileyonlinelibrary.com/journal/nbm Copyright  2011 John Wiley & Sons, Ltd. NMR Biomed. 2012; 25: 427–442




susceptibility effects. This demonstrates both the superior SNR
and resolution of the fluidized bed. At a diameter of less than
700mm, the alginate microspheres are solid throughout;
otherwise, they can have a molten core (72).
31P MRS resolution, SNR, viability and pH
Comparison of the b-NTP time course between 20% and 35%
oxygen in the perfusion medium of the fluidized-bed BAL
revealed that the hepatocytes died at approximately 10 h after
inoculation and remained viable for the course of the
experiments, about 28 h, respectively (Fig. 9B, right graph). Our
data suggest that, during the first 5 h of perfusion with 35%
oxygen, the hepatocytes recover from the hypoxic isolation
process, as indicated by an increase from an acidic intracellular
pH 6.9 to a physiological level of pH 7.4 (Fig. 9B), resulting in a
31P MR spectrum (Fig. 9A) that is similar to the 31P MR spectrum
from intact liver (29). Calciumwas used as gelling agent, similar to
previous alginate-encapsulated BAL systems (27,73), and poten-
tial barium toxicities could be avoided; however, there was no
difference in the 31P MRS time course using barium. Although
calcium is an extremely potent intracellular secondary messen-
ger, both calcium and barium have such high affinities for
carboxylate groups that they are relatively unavailable, or the
encapsulates would lose integrity and disintegrate. Although the
hepatocytes were maintained for 28 h using 35% oxygen with
little change in the b-NTP peak area (Fig. 9B), they exhibited a
high degree of anaerobic glycolysis not typical in liver, as
indicated by the analysis of medium (68). Therefore, although
in vivo 31P MRS permits indirect evidence for metabolic function,
in vivo 13C MRS is required for noninvasive dynamicmeasurement
of metabolic pathways.
13C MRS to monitor real-time metabolism
Previous in vivo 13C MRS studies of MR-compatible BALs have
focused on the perturbation of intermediary metabolism as a
result of xenobiotic exposure (16–18). With the advent of
Figure 8. Confocal cross-sectional images of the coaxial bioreactor at culture day 30. (A1–A3) Cells embedded in collagen : Matrigel. (B) Generation-1
coaxial bioreactor. (C1–C4) Cells cultured with alginate : Matrigel beads. Note that the cells are aggregated in A1–A3, but not as extensively in C2–C4,
except along the borders of the alginate beads (C1).





perfusion of bioreactors, the 13C signal from cells and medium
were distinguished by the utilization of diffusion-weighted pulses
(62). With the advent of perfusion of bioreactors, the 13C signal
from cells and medium were distinguished by the utilization of
diffusion-weighted pulses (62). 13C MRS studies were all
performed in suspension bioreactors, primarily for metabolism
studies, as mentioned above (16–18). Indeed, O’Leary et al. (75)
were the first to analyze the media stream in real time by putting
the bioreactor loop through the 13C MR probe; the medium is
called the metabolomic footprint of the cell culture and is
analyzed by itself as a measure of BAL performance (68).
Figure 10A shows 13C NMR of the fluidized-bed BAL containing
alginate-encapsulated rat hepatocytes, perfused with
u-13C-glucose, illustrating the time course of 13C-glucose
incorporation into C1 of glycogen ( 102 ppm). The peak
reaches steady-state incorporation by about 6 h, and the rate of
glycogen synthesis can be determined by fitting the peak area to
an exponential. The one problem with a fluidized-bed BAL is that
pulse sequences to eliminate the large 13C signal from flowing
medium, such as diffusion-weighted 1H MR (62), also negatively
affect the signals emanating from the percolating cells. Therefore,
diffusion-weighted 13C MRS did not help to increase SNR and,
using a one-pulse sequence, caused the 25mM glucose signal to
swamp the 13C MR spectrum. Herein lies the inherent conundrum
of in vivo MRS: replace the fluidized bed with a packed bed and
redesign the bioreactor with a flow distributor (15) and
containment baffles (12), so that a diffusion-weighted pulse
sequence can be used for superior in vivo 13C MR spectral quality,
but at the expense of a higher surface velocity of medium across
the encapsulate, creating nonphysiological shear conditions that
could affect metabolism or destroy the encapsulate (15).
Figure 10B shows the same fluidized-bed BAL, but containing a
rat hepatoma cell line, JM-1. The spectrum shows the various
13C resonances representing the a and b conformations of
2-13C-glucose. The inset time course is the C2 position of lactate
( 69 ppm) excreted from the hepatocyte cytosol into the
medium. Indeed, 1H NMR of the medium and the cell extract at
the end of the experiment established that this signal was almost
entirely from the medium. The rate of formation is linear and can
be fitted to determine lactate production and the metabolic
phenotype of the hepatocytes. Normally, rat hepatocytes should
not produce lactate, as liver is involved in the Cori cycle for the
conversion of lactate derived from exercising muscle to glucose.
Lactate production is typical of cancer cells, and thus little was
detected in the 13C MR spectral time course of perfused primary
rat hepatocytes shown in Fig. 10A; this is an ideal functional assay
of BALs and, in particular, for the determination of whether
the culture is hypoxic. Indeed, this 13C MRS assay is ideal for
dynamically changing the oxygen content of the medium as the
culture grows, or depending on the cell distribution within the
bioreactor, as this can be performed essentially in real time, whilst
the oxygen concentration is increased or decreased.
Figure 10. (A) The 18-h in vivo 13CMR spectral time course of the fluidized-bed bioreactor inoculatedwith 500-mm-diameter electrostatically encapsulated
alginate beads containing 3.5 107 rat hepatocytes/mL and perfusedwith 25mM u-13C-glucose, showing the increase in peak representing the C1-glycogen
at 102ppm. (B) In vivo 13C MR spectrum of perfused alginate-encapsulated JM-1 cells and the 15-h time course of C2-lactate above the spectrum.
Figure 9. (A) Comparison of in vivo 31P MR spectra from the hollow fiber
membrane bioreactor (29) and fluidized-bed bioreactor (74) obtained in
60min vs 30 min, demonstrating the superior signal-to-noise ratio (SNR)
and resolution of the fluidized-bed bioreactor. (B) Graph of intracellular pH
(left) andb-nucleotide triphosphate (b-NTP) (right) of rat hepatocytes perfused
with medium subjected to 20% and 35% oxygen treatments. GPC, glycero-
phosphocholine; NAD(H), nicotinamide adenine dinucleotide; Pi, inorganic
phosphate; PME, phosphomonoester; UDPG, uridine diphosphoglucose.
wileyonlinelibrary.com/journal/nbm Copyright  2011 John Wiley & Sons, Ltd. NMR Biomed. 2012; 25: 427–442





Although MR-compatible BAL technology was first introduced
three decades ago (8), there is still no report of a long-term
device, longer than 8 h (Table 1), for primary hepatocytes. These
early suspension and, more recently, perfused BAL studies
focused on short-term xenobiotic perturbation and were not
intended for long-term use (see suspension category references
in Table 1). However, some have focused on the characterization
of the function and imaging cell distribution for tissue
engineering analysis (29,59,69), and this review demonstrates
the application of multinuclear MRS using 31P (Figs 4 and 9), 13C
(Fig. 10), 19F (Fig. 5) and 1H MRI [velocity-encoded 1H MRI (Fig. 7A)
and T2-weighted
1H MRI (Fig. 6)]. The integrity and inoculation
efficiency of BAL have been determined using diffusion-weighted
1H MRI and T2-weighted MRI, and dynamic contrast FAST
1H MRI
has been applied to determine the kinetics of these agents on
liver using a hollow fiber BAL as a model (69).
To recap, Table 1 shows a summary of the various MRS/MRI
metrics for the four categories of bioreactor: (i) suspension (8); (ii)
entrapment (3,9); (iii) microcarriers (4,13); and (iv) membrane (14).
The suspension bioreactor suffers the worse mass transfer, being
packed in a 5-mm NMR tube with a diffusion distance of
approximately 30mm from the cell mass surface to the bottom of
the NMR tube (8,16–18). However, the suspension BAL has the best
global density, resulting in the best SNR and excellent spectral
resolution and line shape (Table 1). In addition, few perfused
MR-compatible BAL studies used air, or 20% oxygen (26,59) or 95%
oxygen (19–23,27,29,69). From our results, 20% oxygen did not
permit full recovery of b-NTP (Fig. 9B). Hepatocytes require
relatively large amounts of oxygen. The oxygen buffering capacity
of hemoglobin, which increases the oxygen concentration by
nearly two orders of magnitude, maintains an oxygen gradient
across the acinus of 8% to 3% (high to low) where blood exits the
liver, and this is lacking in BAL perfusion systems (15).
The agarose thread encapsulation BAL (19–25) and the
packed-bed bioreactor (26–28) exhibit sufficient 31P MRS SNR
and spectral resolution within 15min. However, channels can form
with gel threads and a packed-bed bioreactor (15). In addition, the
diffusion distance is larger than the desired 0.2mm (26–28), or the
diffusion distance is sufficient, but 95% oxygen was used (19–25).
The MR-compatible BAL study, using the two coaxial BAL
prototypes shown in Fig. 6A, compared diffusion distances of
0.2 and 0.5mm, and found that only the former bioreactor
maintained viability (29). Other studies have shown that BALs
surviving with 20% oxygen require diffusion distances of less than
200mm (43,76–79). Therefore, it may have been necessary to use
95% oxygen with these MR-compatible packed-bed alginate
encapsulate bioreactors (26–28), but not the agarose gel threads
(Table 1). Indeed, BALs with 95% oxygenation of the medium have
survived for weeks (15,80,81). Hepatocytes that survive the initial
hyperoxic stress will move within the bioreactors to a region of
optimal oxygen concentration via philopodia (82), and as
demonstrated in the long-term cultures in Fig. 8. For example,
rat hepatocytes grown in a multicoaxial bioreactor (33) have been
shown to migrate and form organoid structures at an optimal
distance from the oxygen sources after several days of culture (77),
as illustrated in Fig. 8. Diffusion-weighted 1HMRI would be ideal for
monitoring this phenomenon.
Although the MR-compatible coaxial hollow fiber bioreactor
design maintains a homogeneous diffusion distance and has
been shown to maintain hepatocyte viability for weeks (77), the
relative amount of biomass vs bioreactor/medium, or the global
density (31), is much less than in entrapment and suspension
bioreactors. Therefore, the temporal MR spectral resolution is
relatively poor (29), generating inferior kinetic data (Table 1).
However, if the goal is to monitor long-term liver function on a
daily basis, typical of tissue engineering studies, in vivo 13C/31P/19F
spectra, which require several hours to acquire, would be sufficient
to achieve this goal, and much less laborious for a comparable
temporal resolution when compared with high-resolution MRS
analysis of media streams (68). To increase the SNR of the 19F MRS
assay of phase I and phase II drug metabolism, described in Fig. 5,
or the in vivo 13C MRS quantification of the lactate production rate,
described in Fig. 10B, the volume of medium could be minimized
during the MRS measurement to increase the concentration of
drugs or metabolites in the medium. For example, if the volume of
mediumwas decreased by half, the medium lactate concentration
would double, resulting in a four-fold increase in SNR for a given
time.
There has never been an MR-compatible BAL reported that
utilizes liver cells withmicrocarriers, and this is the first report of such
a BAL, described in Figs 1A and 4. Although, the first BAL used in
clinical trials (83) employed hepatocytes on microcarriers in the
initial development to increase function, they were inoculated in a
hollow fiber bioreactor with a diffusion distance close to the 0.2-mm
range, unlike the 10-mm range used in this study. It was discovered
that the aggregation of cells caused by cell-to-cell surface binding
through calcium-dependent adhesion molecules caused large
aggregates to form, resulting in large diffusion distances, as can be
vaguely seen in Fig. 3C. Indeed, liver spheroid cultures depend
on this aggregation effect for formation (31) and, to avoid this,
spheroids (12) and microcarriers (13) are typically immobilized in a
packed-bed bioreactor. The shear forces generated by the 1208
rotation of the hybrid hollow fiber–microcarrier BAL caused large
numbers of microcarriers to aggregate.
The fluidized-bed BAL described herein (Figs 1C and 2)
contains sufficient biomass to yield an adequate 31P MRS SNR in
30min (Fig. 9A), yet maintains the maximum diffusion distance of
approximately 0.2mm, resulting in the best characteristics of
the various bioreactor types (Table 1). Oxygen studies have
demonstrated that the use of 35% oxygen was required to
maintain viability for the duration of the study, 28 h (Figs 9B and
10A), and probably beyond. The bioreactor is versatile and
designs have been constructed to fit conventional 5-mm MR
probes, although a 10-mm NMR tube was used in this study. The
alginate eliminates aggregation; however, it is not an extracellular
matrix found in liver tissue, and therefore hepatocytes typically
do not migrate as actively as they do in endogenous extracellular
matrices, as shown in the confocal micrograph comparing
MatrigelTM : collagen type 1 with alginate (Fig. 8).
In short, MRS and MRI are powerful tools for noninvasive
analysis in tissue engineering of the liver. Magnetic susceptibility
effects and filling factors are important in the SNR of MRS andMRI
quality, and some knowledge of MR probe construction can help
to improve SNR, but has little effect on the innate magnetic
susceptibility of the BAL design, especially designs with integral
oxygenation (59,84).
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